RxDoctor Payments Data

Muhammad Farooq, MD

Hospitalist · Hartford, CTNPI 1740630417

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,147 of the $5,215 with a category attached, or 60.3%. Boston Scientific accounts for 62.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $3,099 and has fallen 91.7% since, to $257 in 2025. Among hospitalist clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,215in general payments, 2019–2025

Across 73 payments — averaging $71.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Wilson Cook Medical Incorporated$692
  • AbbVie$410
  • Cook Medical LLC$374
  • Takeda Pharmaceuticals U.S.A., Inc.$105
  • Johnson & Johnson$73
  • plus $312 from 9 others

What the payments were for

  • Travel & lodging$3,14760%
  • Food & beverage$2,06840%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,215 in reported general payments places this provider in the 95th percentile of 349 hospitalist providers in Connecticut.

See all hospitalist providers in Connecticut

Medicare billing

Part B allowed, 2024
$5,725
Medicare patients
29
Services billed
49

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl12$215

Paid to pharmacies, not to this prescriber.

Other hospitalist in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →